180 related articles for article (PubMed ID: 33376135)
21. α and β catalytic subunits of cAMP-dependent protein kinase regulate formoterol-induced inflammatory gene expression changes in human bronchial epithelial cells.
Hamed O; Joshi R; Mostafa MM; Giembycz MA
Br J Pharmacol; 2022 Sep; 179(18):4593-4614. PubMed ID: 35735057
[TBL] [Abstract][Full Text] [Related]
22. Differences in the efficacy and safety among inhaled corticosteroids (ICS)/long-acting beta2-agonists (LABA) combinations in the treatment of chronic obstructive pulmonary disease (COPD): Role of ICS.
Latorre M; Novelli F; Vagaggini B; Braido F; Papi A; Sanduzzi A; Santus P; Scichilone N; Paggiaro P
Pulm Pharmacol Ther; 2015 Feb; 30():44-50. PubMed ID: 25445928
[TBL] [Abstract][Full Text] [Related]
23. Inflammatory stimuli inhibit glucocorticoid-dependent transactivation in human pulmonary epithelial cells: rescue by long-acting beta2-adrenoceptor agonists.
Rider CF; King EM; Holden NS; Giembycz MA; Newton R
J Pharmacol Exp Ther; 2011 Sep; 338(3):860-9. PubMed ID: 21622733
[TBL] [Abstract][Full Text] [Related]
24. The effects of asthma medications on reactive oxygen species production in human monocytes.
Tsai MK; Lin YC; Huang MY; Lee MS; Kuo CH; Kuo PL; Lin CH; Hung CH
J Asthma; 2018 Apr; 55(4):345-353. PubMed ID: 28696794
[TBL] [Abstract][Full Text] [Related]
25. Long-acting beta 2 agonists suppress IP-10 expression in human bronchial epithelial cells.
Chien JW; Chu YT; Yang SN; Kuo CH; Wang WL; Kuo PL; Jong YJ; Hung CH
J Investig Med; 2012 Oct; 60(7):1048-53. PubMed ID: 22914602
[TBL] [Abstract][Full Text] [Related]
26. Impact of Phosphodiesterase 4 Inhibition on the Operational Efficacy, Response Maxima, and Kinetics of Indacaterol-Induced Gene Expression Changes in BEAS-2B Airway Epithelial Cells: A Global Transcriptomic Analysis.
Joshi R; Yan D; Hamed O; Mostafa MM; Joshi T; Newton R; Giembycz MA
Mol Pharmacol; 2019 Jul; 96(1):56-72. PubMed ID: 31036559
[TBL] [Abstract][Full Text] [Related]
27. Treatment of persistent asthma with Symbicort (budesonide/formoterol inhalation aerosol): an inhaled corticosteroid and long-acting beta2-adrenergic agonist in one pressurized metered-dose inhaler.
Berger WE; Noonan MJ
J Asthma; 2010 May; 47(4):447-59. PubMed ID: 20528601
[TBL] [Abstract][Full Text] [Related]
28. Long-acting β2-adrenoreceptor agonists suppress type 1 interferon expression in human plasmacytoid dendritic cells via epigenetic regulation.
Kuo CH; Yang SN; Tsai YG; Hsieh CC; Liao WT; Chen LC; Lee MS; Kuo HF; Lin CH; Hung CH
Pulm Pharmacol Ther; 2018 Feb; 48():37-45. PubMed ID: 28987803
[TBL] [Abstract][Full Text] [Related]
29. Phosphodiesterase 4 inhibitors augment the ability of formoterol to enhance glucocorticoid-dependent gene transcription in human airway epithelial cells: a novel mechanism for the clinical efficacy of roflumilast in severe chronic obstructive pulmonary disease.
Moodley T; Wilson SM; Joshi T; Rider CF; Sharma P; Yan D; Newton R; Giembycz MA
Mol Pharmacol; 2013 Apr; 83(4):894-906. PubMed ID: 23389862
[TBL] [Abstract][Full Text] [Related]
30. Understanding how long-acting β
Newton R; Giembycz MA
Br J Pharmacol; 2016 Dec; 173(24):3405-3430. PubMed ID: 27646470
[TBL] [Abstract][Full Text] [Related]
31. Dose-response relationship of ICS/fast-onset LABA as reliever therapy in asthma.
Beasley R; Harper J; Bird G; Dunphy H; Semprini A; Pavord ID; Papi A; Weatherall M
BMC Pulm Med; 2019 Dec; 19(1):264. PubMed ID: 31883519
[TBL] [Abstract][Full Text] [Related]
32. Budesonide promotes airway epithelial barrier integrity following double-stranded RNA challenge.
Rimmer C; Hetelekides S; Eliseeva SI; Georas SN; Veazey JM
PLoS One; 2021; 16(12):e0260706. PubMed ID: 34871316
[TBL] [Abstract][Full Text] [Related]
33. Symbicort® Maintenance and Reliever Therapy (SMART) and the evolution of asthma management within the GINA guidelines.
Lin J; Zhou X; Wang C; Liu C; Cai S; Huang M
Expert Rev Respir Med; 2018 Mar; 12(3):191-202. PubMed ID: 29400090
[TBL] [Abstract][Full Text] [Related]
34. Inhaled corticosteroid therapy for patients with persistent asthma: learnings from studies of inhaled budesonide.
Chipps BE
Allergy Asthma Proc; 2009; 30(3):217-28. PubMed ID: 19344546
[TBL] [Abstract][Full Text] [Related]
35. A bolus of inhaled budesonide rapidly reverses airway subsensitivity and beta2-adrenoceptor down-regulation after regular inhaled formoterol.
Aziz I; Lipworth BJ
Chest; 1999 Mar; 115(3):623-8. PubMed ID: 10084466
[TBL] [Abstract][Full Text] [Related]
36. Effect of budesonide and formoterol on IL-6 and IL-8 release from primary bronchial epithelial cells.
Strandberg K; Palmberg L; Larsson K
J Asthma; 2008 Apr; 45(3):201-3. PubMed ID: 18415826
[TBL] [Abstract][Full Text] [Related]
37. Formoterol synergy with des-ciclesonide inhibits IL-4 expression in IgE/antigen-induced mast cells by inhibiting JNK activation.
Sun YH; Ge LT; Jiang JX; Shen HJ; Jia YL; Dong XW; Sun Y; Xie QM
Eur J Pharmacol; 2015 Aug; 761():161-7. PubMed ID: 26003274
[TBL] [Abstract][Full Text] [Related]
38. Induction of regulator of G-protein signaling 2 expression by long-acting β2-adrenoceptor agonists and glucocorticoids in human airway epithelial cells.
Holden NS; George T; Rider CF; Chandrasekhar A; Shah S; Kaur M; Johnson M; Siderovski DP; Leigh R; Giembycz MA; Newton R
J Pharmacol Exp Ther; 2014 Jan; 348(1):12-24. PubMed ID: 24163441
[TBL] [Abstract][Full Text] [Related]
39. Increasing doses of inhaled corticosteroids compared to adding long-acting inhaled beta2-agonists in achieving asthma control.
O'Byrne PM; Naya IP; Kallen A; Postma DS; Barnes PJ
Chest; 2008 Dec; 134(6):1192-1199. PubMed ID: 18689590
[TBL] [Abstract][Full Text] [Related]
40. As-needed ICS-LABA in Mild Asthma: What Does the Evidence Say?
Domingo C; Rello J; Sogo A
Drugs; 2019 Nov; 79(16):1729-1737. PubMed ID: 31584145
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
